Diagnostic potential of natriuretic peptides in the occult phase of golden retriever muscular dystrophy cardiomyopathy

Journal of Veterinary Internal Medicine

Volumn 18, Issue 6, 2004, Pages 845-850

  Chetboul, Valérie ^a,b   Tessier Vetzel, Dominique ^a,b   Escriou, Catherine ^a   Tissier, Renaud ^a,b   Carlos, Carolina ^a   Boussouf, Maya ^a   Pouchelon, Jean Louis ^a,b   Blot, Stéphane ^a,b   Derumeaux, Geneviève ^b  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b INSERM   (France)

Author keywords

Brain natriuretic peptide; Cardiology; Dog; Duchenne cardiomyopathy; Echocardiography

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ANIMAL MUSCULAR DYSTROPHY; ARTICLE; CARDIOMYOPATHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOG; ECHOCARDIOGRAPHY; HEART VENTRICLE FUNCTION; IMMUNOHISTOCHEMISTRY; NONHUMAN; RADIOIMMUNOASSAY;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FEMALE; MALE; MUSCULAR DYSTROPHY, ANIMAL; NATRIURETIC PEPTIDE, BRAIN; PEDIGREE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

ANIMALIA; CANIS FAMILIARIS;

EID: 11444257918     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2004)18<845:DPONPI>2.0.CO;2     Document Type: Article

References (38)

1. Edwards BS, Zimmerman RS, Schwab TR, et al. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988;62:191-195.
2. Richards AM, Tonolo G, Tree M, et al. Atrial natriuretic peptides and renin release. Am J Med 1988;84:112-118.
3. Raine AE, Erne P, Bürgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986;315:533-537.
4. Ganau A, Devereux RB, Atlas SA, et al. Plasma atrial natriuretic factor in essential hypertension: relation to cardiac size, function and systemic hemodynamics. J Am Coll Cardiol 1989;14:715-724.
5. Kohno M, Horio T, Yokokawa K, et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin converting enzyme inhibitor. Am J Med 1995;98:257-265.
6. Tsutamoto T, Wada A, Maeda KA, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-516.
7. Moe GW, Grima EA, Howard RJ, et al. Dual natriuretic peptide system in experimental heart failure. J Am Coll Cardiol 1993;22:891-898.
8. Moe GW, Grima EA, Wong NL, et al. Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. J Am Coll Cardiol 1996;27:720-727.
9. Haggström J, Hansson K, Karlberg BE, et al. Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels. Am J Vet Res 1994;55:698-703.
10. Haggström J, Hansson K, Kvart C, et al. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin- aldosterone system and atrial natriuretic peptide concentration in dogs. Am J Vet Res 1997;58:77-82.
11. Haggström J, Hansson K, Kvart C, et al. Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease. J Vet Cardiol 2000;2:7-16.
12. Boswood A, Attree S, Page K. Clinical validation of a proANP 31-67 fragment ELISA in the diagnosis of heart failure in the dog. J Small Anim Pract 2003;44:104-108.
13. Tidholm A, Haggström J, Hansson K. Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs. Am J Vet Res 2001;62:961-967.
14. MacDonald KA, Kittleson MD, Munro C, et al. Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. J Vet Intern Med 2003;17:172-177.
15. Biondo AW, Ehrhart EJ, Sisson DD, et al. Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy. Vet Pathol 2003;40:501-506.
16. Cooper BJ, Winand NJ, Stedman H, et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 1988;334:154-156.
17. Moise NS, Valentine BA, Brown CA, et al. Duchenne's cardiomyopathy in a canine model: electrocardiographic and echocardiographic studies. J Am Coll Cardiol 1991;17:812-20.
18. Valentine BA, Cooper BJ, de Lahunta A, et al. Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J Neurol Sci 1988;88:69-81.
19. Valentine BA, Cummings JF, Cooper BJ. Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model. Am J Pathol 1989;135:671-678.
20. Bartlett RJ, Winand NJ, Secore SL, et al. Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs. Am J Vet Res 1996;57:650-654.
21. Sharp NJ, Kornegay JN, Van Camp SD, et al. An error in dystrophin mRNA processing in Golden Retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 1992;13:115-121.
22. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
23. Hansson K, Häggström J, Kvart C, et al. Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in Cavalier King Charles spaniels with and without left atrial enlargement. Vet Radiol Ultrasound 2002;43:568-575.
24. Solomon LR, Atherton JC, Bobinski H, et al. Effect of dietary sodium chloride and posture on plasma immunoreactive atrial natriuretic peptide concentrations in man. Clin Sci 1987;72:201-208.
25. Chetboul V, Adam M, Deprez I, et al. Expression of biologically active atrial natriuretic factor following intrahepatic injection of a replication-defective adenoviral vector in dogs. Human Gene Ther 1999;10:281-90.
26. Morrison SA, Moise NS, Scarlett J, et al. Effect of breed and body weight on echocardiographic values in four breeds of dogs of differing somatotype. J Vet Intern Med 1992;6:220-224.
27. Matsubara H, Nishikawa M, Umeda Y, et al. The role of atrial pressure in secreting atrial natriuretic polypeptides. Am Heart J 1987;113:1457-1462.
28. Azizi C, Maistre G, Kalotka H, et al. Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure. J Endocrinol 1996;148:51-57.
29. Kawai H, Adachi K, Kimura C, et al. Secretion and clinical significance of atrial natriuretic peptide in patients with muscular dystrophy. Arch Neurol 1990;47:900-904.
30. Yanagisawa A, Yokota N, Miyagawa M, et al. Plasma level of atrial natriuretic peptide in patients with Duchenne's progressive muscular dystrophy. Am Heart J 1990;120:1154-1158.
31. McDonagh TA, Robb SD, Murdoch JJ, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
32. Lerman A, Gibbons RJ, Rodeheffer RJ, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-1109.
33. Wei CH, Heublin DM, Perella MA, et al. Natriuretic peptide system in human heart failure. Circulation 1993;88:1004-1049.
34. Motwani JG, Mc Alpine H, Kennedy N, et al. Plasma brain natriuretic peptide as an indicator of angiotensin converting enzyme inhibition after myocardial infarction. Lancet 1993;341:1109-1113.
35. Nagagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy: evidence for BNP as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 1995;96:1280-1287.
36. Maeda K, Takayoshi T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-832.
37. Giglio V, Pasceri V, Messano L, et al. Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy. J Am Coll Cardiol 2003;42:309-316.
38. Agretto A, Politano L, Bossone E, et al. Pulsed Doppler tissue imaging in dystrophinopathic cardiomyopathy. J Am Soc Echocardiogr 2002;15:891-899.